Available Forms: Prefilled autoinjector
Available Strengths: 70 mg, 140 mg
Reference Brands: Aimovig (USA/EU)
Category: Neurology
Erenumab is a monoclonal antibody used for the prevention of migraines in adults. It works by blocking the CGRP (Calcitonin Gene-Related Peptide) receptor, which plays a key role in migraine attacks. Administered as a subcutaneous injection once monthly, it is available in 70 mg and 140 mg strengths via prefilled pen or syringe. Erenumab helps reduce the frequency of migraine days and is generally well-tolerated.
Quick Response Guaranteed | Verified Suppliers
Strength: 125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
Strength: 50 mg, 100 mg
Form: Tablets
Reference Brands: Ubrelvy (USA/India)
Strength: 100 mg
Reference Brands: Tasmar (USA/EU)
Strength: 50 mg ,100 mg
Reference Brands: Xadago (USA/EU)
By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under ‘Fair use.’
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Stay updated on pharma trends and marketplace opportunities.
Online · B2B Pharma · Medical Tourism · NPP